Investment objective & strategy
As of June 30, 2025 · prospectusObjective. Total return greater than that of its benchmark, the GMO Strategic Opportunities Allocation Index, an internally maintained composite index computed by GMO, consisting of 75% MSCI World Index (MSCI Standard Index Series) and 25% Bloomberg U.S. Aggregate Index.
Strategy. The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for other accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests in direct investments, shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds and the Alternative Funds, and shares of GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and … The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for other accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests in direct investments, shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds and the Alternative Funds, and shares of GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds asset class exposures in response to changes in GMOs investment outlook and its assessment of market valuations and may use redemptions or purchases of Fund shares to rebalance the Funds investments. The factors GMO considers and investment methods GMO uses can change over time. The Fund is permitted to invest in any asset class (e.g., U.S. equity, non-U.S. equity, emerging country equity, U.S. fixed income, non-U.S. fixed income, emerging country debt, and commodities), strategy (e.g., long/short and event-driven strategies), sector, country, or region and at times may have substantial exposure to a single asset class, sector, country, region, issuer, or currency and companies with similar market capitalizations. In addition, the Fund is not restricted in its exposure to any particular market and may invest in securities of companies of any market capitalization and, in the case of debt instruments, of any credit quality (including below investment grade securities, commonly referred to as high yield or junk bonds), maturity and duration. The Fund typically has substantial exposure to derivatives and short-sales. Leverage is not a principal component of the Funds investment strategy. However, because of its derivative exposure, the Fund may at times have gross investment exposure in excess of its net assets (i.e., the Fund may be leveraged) and, therefore, may be subject to higher risk of loss during those times than if the Fund were not leveraged. In seeking to achieve the Funds investment objective, GMO may invest a significant portion of the Funds net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in money market funds unaffiliated with GMO and directly in the types of investments typically held by money market funds.
Top holdings
As of Feb. 28, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| GMO Alternative Allocation Fund | — | $12.93M | 18.13% |
| GMO International Equity Fund | — | $12.63M | 17.71% |
| GMO Asset Allocation Bond Fund | — | $6.77M | 9.49% |
| GMO International Opportunistic Value Fund | — | $5.90M | 8.28% |
| GMO US Opportunistic Value Fund | — | $5.60M | 7.85% |
| GMO US Equity Fund | — | $5.49M | 7.70% |
| GMO-Usonian Japan Value Creation Fund | — | $5.39M | 7.57% |
| GMO Emerging Markets Fund | — | $4.23M | 5.94% |
| GMO Quality VI | GQLOX | $2.35M | 3.30% |
| GMO Emerging Markets ex-China Fund | — | $1.73M | 2.42% |
Portfolio moves
Nov 30, 2025 → Feb 28, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| GMO Global Asset Allocation Fund · GMWAX, GMWRX, GMOOX | 89% | 0.79% |
| GMO Global Equity Allocation Fund · GMGEX, GAAUX, GMADX | 66% | 0.58% |
| GMO Global Developed Equity Allocation Fund · GWOAX | 60% | 0.53% |
Advisers
| Firm | Role |
|---|---|
| Grantham Mayo van Otterloo & Co LLC | Adviser |
Footnotes
- Expense ratio as of June 30, 2025, from the fund's prospectus.
- Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.